Company attributes
Location
B2X
Pitchbook URL
Parent Organization
Number of Employees (Ranges)
11 – 50
Email Address
info@evbio.tech0
Phone Number
+31850070392
Full Address
Zernikelaan 8, 9747 AA Groningen0
Zernikepark 12, 9747 AN Groningen0
Investors
Founded Date
July 2018
Total Funding Amount (USD)
4,700,000
Latest Funding Round Date
March 23, 2023
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
4,700,000
EV Biotech implements a synergistic approach of microbial cell factory development by combining data driven predictive algorithms with strain design and development. This allows us to develop strains more cost-effectively, increase the successful output, and reduce time to market.
Our Approach
EV Biotech is currently developing four EV proprietary strains. These strains can produce Vanillin, PHAs, Spider silk, and Terpenes. These compounds were chosen after in-depth market research.
Revolutionising strain development for sustainable compound production.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
